Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Comparative bioavailability assessment between 4 x 60 mg R107 tablets administered orally and 0.5mg/kg ketamine IV infusion over 40 minutes in healthy male and female participants under fasting conditions.


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12618001135202

Organisation Name: Zenith Technology Corporation Limited

Overal Status: Not yet recruiting

Start Date: 18/07/2018

Brief Summary: The objective of this study is to evaluate the comparative bioavailability of the test formulation relative to that of a reference formulation, following oral administration of a single dose of 4 x 60 mg R107 tablets and 0.5 mg/kg ketamine IV infusion over 40 minutes to healthy male and female subjects under fasting conditions.

Countries:
  • New Zealand
Conditions:
  • Depression
  • Anxiety


Total execution time in seconds: 0.086030960083008